Brownlee W, et al. Early focal inflammatory disease is associated with long-term cognitive performance in relapse-onset multiple sclerosis. ECTRIMS 2018, abstract 97.
Besluit sluisgeneesmiddel ravulizumab (Ultomiris)
apr 2024 | Neuro-musculair
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen